11.03.2019 13:01:00

Alfardan Medical with Northwestern Medicine select Allscripts

Allscripts first client in Qatar to provide first-of-its-kind ambulatory care services

CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Alfardan Group, one of the leading family-owned conglomerates in Qatar, and Chicago-based Northwestern Medicine have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine. The project is a part of Allscripts expansion in the Middle East and will provide ambulatory care services including Sunrise™ Ambulatory, Sunrise™ Surgery, Sunrise™ Radiology, Allscripts® Clinical Performance Management, Allscripts Lab™ and iPro Anesthesia™.

Based in Burj Alfardan, Lusail, Alfardan Medical with Northwestern Medicine is the first of Alfardan Group's investments in the health sector, as part of its social responsibility toward the State of Qatar and its vision to develop projects that will contribute to the realization of the Qatar National Vision 2030. Alfardan Medical with Northwestern Medicine will offer high quality healthcare and a range of multidisciplinary medical specializations in a unique clinical environment.

Used by healthcare organizations across the globe, Allscripts Sunrise is a fully integrated electronic health record that connects all aspects of care, including ambulatory, surgical, radiology, and laboratory services. Built to enable efficient and safe care, Sunrise is a physician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience for the consumer.

"Alfardan Group has built its reputation on offering our clients a lifestyle in keeping with the quality and premium services that they value,” said Omar Hussain Alfardan, President and Chief Executive Officer of Alfardan Group. "We believe Allscripts is the suitable partner to help us deliver world-class integrated healthcare to Qatar.”

"We are pleased to have the opportunity to partner with Alfardan Group and Northwestern Medicine in its new project," said Alan Fowles, President of Allscripts Global. "With the help of this new partnership in the Middle East, we can demonstrate the value of Allscripts commitment to open, connected communities of care to its people and across the globe.”

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About AMNM

About Alfardan Medical with Northwestern Medicine
Medical with Northwestern Medicine (AMNM) is an ambulatory care center that provides high quality, multidisciplinary medical specializations, based in Burj Alfardan, Lusail. AMNM is an international collaboration between Alfardan Group and Northwestern Medicine (Chicago, U.S.A.). They each share a vision and a set of guiding values for the establishment, execution and operation of AMNM.

For more information, please visit the AMNM website at www.amnm.com

© 2019 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Nachrichten zu Allscripts Healthcare Solutions Incmehr Nachrichten

26.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor einem Jahr gekostet (finanzen.at)
19.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust wäre bei einem Investment in Allscripts Healthcare Solutions von vor 10 Jahren angefallen (finanzen.at)
12.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger mit einem Investment in Allscripts Healthcare Solutions von vor 5 Jahren verloren (finanzen.at)
05.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 3 Jahren verloren (finanzen.at)
29.08.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte eine Allscripts Healthcare Solutions-Investition von vor einem Jahr eingebracht (finanzen.at)
22.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor 10 Jahren gekostet (finanzen.at)
15.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 5 Jahren verdient (finanzen.at)
08.08.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte ein Investment in Allscripts Healthcare Solutions von vor 3 Jahren eingebracht (finanzen.at)

Analysen zu Allscripts Healthcare Solutions Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Allscripts Healthcare Solutions Inc 9,20 4,55% Allscripts Healthcare Solutions Inc